Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A

References

• Damiani G, Bragazzi NL, Karimkhani Aksut C, et al. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med. 2021;8:743180. doi:10.3389/fmed.2021.743180
   PubMed Web of Science ®Google Scholar
• Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475
   PubMed Web of Science ®Google Scholar
• Tashiro T, Sawada Y. Psoriasis and systemic inflammatory disorders. Int J Mol Sci. 2022;23(8):4457. doi:10.3390/ijms23084457
   PubMed Web of Science ®Google Scholar
• Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165–1172. doi:10.1111/ijd.14032
   PubMed Web of Science ®Google Scholar
• Bolotna L, Sarian O. Psychopathological disorders as comorbidity in patients with psoriasis (review). Georgian Med News. 2020;2020 (301):143–147.
   Google Scholar
• Megna M, Camela E, Battista T, et al. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opin Drug Saf. 2023;22(1):25–41. doi:10.1080/14740338.2023.2173170
   PubMed Web of Science ®Google Scholar
• Megna M, Camela E, Battista T, et al. Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opin Drug Saf. 2023;22(1):43–58. doi:10.1080/14740338.2023.2173171
   PubMed Web of Science ®Google Scholar
• Bakshi H, Nagpal M, Singh M, Dhingra GA, Aggarwal G. Treatment of psoriasis: a comprehensive review of entire therapies. Curr Drug Saf. 2020;15(2):82–104. doi:10.2174/1574886315666200128095958
   PubMed Web of Science ®Google Scholar
• Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33(1):173–180. doi:10.1007/s10103-017-2360-1
   PubMed Web of Science ®Google Scholar
• Liu C, Ma R, Wang L, et al. Rehmanniae Radix in osteoporosis: a review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J Ethnopharmacol. 2017;198:351–362. doi:10.1016/j.jep.2017.01.021
   PubMed Web of Science ®Google Scholar
• Xiao S, Wang C, Yang Q, Xu H, Lu J, Xu K. Rea regulates microglial polarization and attenuates neuronal apoptosis via inhibition of the NF-kappaB and MAPK signalings for spinal cord injury repair. J Cell Mol Med. 2021;25(3):1371–1382. doi:10.1111/jcmm.16220
   PubMed Web of Science ®Google Scholar
• Sun M, Shen X, Ma Y. Rehmannioside A attenuates cognitive deficits in rats with vascular dementia (VD) through suppressing oxidative stress, inflammation and apoptosis. Biomed Pharmacother. 2019;120:109492. doi:10.1016/j.biopha.2019.109492
   PubMed Web of Science ®Google Scholar
• Fu C, Wu Y, Liu S, et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022;289:115021. doi:10.1016/j.jep.2022.115021
   PubMed Web of Science ®Google Scholar
• Chen L, Chen H, Lu Y, et al. Decoding active components in a formulation of multiple herbs for treatment of psoriasis based on three cell lines fishing and liquid chromatography-mass spectrometry analysis. J Pharm Biomed Anal. 2020;186:113331. doi:10.1016/j.jpba.2020.113331
   PubMed Web of Science ®Google Scholar
• Ma WY, Jia K, Zhang Y. IL-17 promotes keratinocyte proliferation via the downregulation of C/EBPalpha. Exp Ther Med. 2016;11(2):631–636. doi:10.3892/etm.2015.2939
   PubMed Web of Science ®Google Scholar
• Xu D, Wang J. Downregulation of cathepsin B reduces proliferation and inflammatory response and facilitates differentiation in human HaCaT keratinocytes, ameliorating IL-17A and SAA-induced psoriasis-like lesion. Inflammation. 2021;44(5):2006–2017. doi:10.1007/s10753-021-01477-0
   PubMed Web of Science ®Google Scholar
• Ortiz-Lopez LI, Choudhary V, Bollag WB. Updated perspectives on Keratinocytes and psoriasis: keratinocytes are more than innocent bystanders. Psoriasis. 2022;12:73–87. doi:10.2147/PTT.S327310
   PubMed Web of Science ®Google Scholar
• Furue M, Furue K, Tsuji G, Nakahara T. Interleukin-17A and keratinocytes in psoriasis. Int J Mol Sci. 2020;21(4):1275. doi:10.3390/ijms21041275
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin M, Zhang LJ. Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis. Cells. 2019;8(8):807. doi:10.3390/cells8080807
   PubMed Web of Science ®Google Scholar
• Matson JP, Cook JG. Cell cycle proliferation decisions: the impact of single cell analyses. FEBS J. 2017;284(3):362–375. doi:10.1111/febs.13898
   PubMed Web of Science ®Google Scholar
• Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008;159(5):1092–1102. doi:10.1111/j.1365-2133.2008.08769.x
   PubMed Web of Science ®Google Scholar
• Harper EG, Guo C, Rizzo H, et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol. 2009;129(9):2175–2183. doi:10.1038/jid.2009.65
   PubMed Web of Science ®Google Scholar
• Coimbra S, Figueiredo A, Castro E, Rocha-Pereira P, Santos-Silva A. The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol. 2012;51(4):389–395; quiz 395–388. doi:10.1111/j.1365-4632.2011.05154.x
   PubMed Web of Science ®Google Scholar
• Zdanowska N, Kasprowicz-Furmanczyk M, Placek W, Owczarczyk-Saczonek A. The role of chemokines in psoriasis-an overview. Medicina. 2021;57(8):754. doi:10.3390/medicina57080754
   PubMedGoogle Scholar
• Dainichi T, Matsumoto R, Mostafa A, Kabashima K. Immune control by TRAF6-mediated pathways of epithelial cells in the EIME (Epithelial Immune Microenvironment). Front Immunol. 2019;10:1107. doi:10.3389/fimmu.2019.01107
   PubMed Web of Science ®Google Scholar
• Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells. 2020;9(4):857. doi:10.3390/cells9040857
   PubMed Web of Science ®Google Scholar
• Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol. 2013;2013:569751. doi:10.1155/2013/569751
   PubMedGoogle Scholar
• Yuan M, Yuan B. Antidepressant-like effects of Rehmannioside A on rats induced by chronic unpredictable mild stress through inhibition of endoplasmic reticulum stress and apoptosis of hippocampus. J Chem Neuroanat. 2022;125:102157. doi:10.1016/j.jchemneu.2022.102157
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu J, Qian H, Wu L, Lv M. Cinnamaldehyde inhibits psoriasis‑like inflammation by suppressing proliferation and inflammatory response of keratinocytes via inhibition of NF‑kappaB and JNK signaling pathways. Mol Med Rep. 2021;24(3). doi:10.3892/mmr.2021.12277
   Web of Science ®Google Scholar
• Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res. 2020;53(1):48. doi:10.1186/s40659-020-00316-0
   PubMed Web of Science ®Google Scholar
• Che D, Hang B, Li Y, Li K, Wang K, Wang H. Livin upregulation in keratinocytes of psoriasis patients to promote adhesion molecule expression. Int J Dermatol. 2023;62(7):900–909. doi:10.1111/ijd.16621
   PubMed Web of Science ®Google Scholar
• Jiang Y, Tsoi LC, Billi AC, et al. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight. 2020;5(20). doi:10.1172/jci.insight.142067
   Web of Science ®Google Scholar
• Zhang L, Ma X, Shi R, et al. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A. Br J Pharmacol. 2023;180(5):628–646. doi:10.1111/bph.15983
   PubMed Web of Science ®Google Scholar
• Albanesi C, Pastore S. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab. 2010;11(3):210–227. doi:10.2174/138920010791196328
   PubMed Web of Science ®Google Scholar
• Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645–653. doi:10.1016/j.jaci.2017.07.004
   PubMed Web of Science ®Google Scholar
• Schonthaler HB, Guinea-Viniegra J, Wculek SK, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39(6):1171–1181. doi:10.1016/j.immuni.2013.11.011
   PubMed Web of Science ®Google Scholar
• Freise N, Burghard A, Ortkras T, et al. Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation. Blood. 2019;134(2):134–146. doi:10.1182/blood.2019000320
   PubMed Web of Science ®Google Scholar
• Benoit S, Toksoy A, Ahlmann M, et al. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol. 2006;155(1):62–66. doi:10.1111/j.1365-2133.2006.07198.x
   PubMed Web of Science ®Google Scholar
• Bai F, Zheng W, Dong Y, et al. Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis. Oncotarget. 2018;9(1):1266–1278. doi:10.18632/oncotarget.22260
   PubMedGoogle Scholar
• Mu Y, Gudey SK, Landstrom M. Non-smad signaling pathways. Cell Tissue Res. 2012;347(1):11–20. doi:10.1007/s00441-011-1201-y
   PubMed Web of Science ®Google Scholar